DPY19L2

From WikiMD's WELLNESSPEDIA

DPY19L2 is a gene that encodes a protein in humans. This protein is a member of the dpy-19-like protein family. Mutations in this gene have been associated with spermatogenic failure and globozoospermia, a rare form of male infertility.

Function[edit]

The DPY19L2 protein is involved in the process of spermatogenesis, the production of sperm cells. It plays a crucial role in the acrosome formation, a structure that develops over the anterior half of the head in the spermatozoa. The acrosome is derived from the Golgi apparatus and contains enzymes that are later used to penetrate the egg during fertilization.

Clinical significance[edit]

Mutations in the DPY19L2 gene are the most common cause of globozoospermia, a severe form of male infertility characterized by the production of round-headed spermatozoa. These sperm cells lack an acrosome, which prevents them from properly fertilizing an egg.

Diagnosis[edit]

Diagnosis of globozoospermia due to DPY19L2 mutations can be made through genetic testing. This can involve sequencing the DPY19L2 gene or performing a microarray to detect deletions or duplications in the gene.

Treatment[edit]

There is currently no cure for globozoospermia caused by DPY19L2 mutations. However, some men with this condition have been able to father children through intracytoplasmic sperm injection (ICSI), a type of in vitro fertilization (IVF) where a single sperm is injected directly into an egg.

See also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.